Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PTC Therapeutics
Pharma
PTC withdraws US approval filing for Duchenne drug Translarna
With the writing apparently on the wall, PTC has called off its latest bid for FDA approval of its Duchenne muscular dystrophy drug Translarna.
Fraiser Kansteiner
Feb 13, 2026 10:05am
PTC wins FDA approval for brain-delivered gene therapy Kebilidi
Nov 14, 2024 11:31am
Europe's CHMP backs Novo's FDA-rejected hemophilia treatment
Oct 18, 2024 11:27am
PTC gets another chance to keep Translarna's EU authorization
May 20, 2024 8:58am
PTC, after rejections, will try again with Translarna at the FDA
Mar 19, 2024 10:10am
The top 10 drugs losing US exclusivity in 2024
Mar 11, 2024 3:00am
